Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The problem of preschool wheeze: new developments, new questions

The problem of preschool wheeze: new developments, new questions The problem of preschool wheeze: new developments, new questions Preschool wheeze is a common and often difficult to treat symptom. It may rarely be the first presentation of a severe underlying condition. Preschool wheeze is clearly a syndrome, not a single entity, and thus ripe for phenotyping. A number of approaches to phenotyping have been adopted. Epidemiology, based on the temporal patterns of symptoms, has taught us a lot about the medium and long-term implications of early life events, but is not useful for treatment planning. Atopic status is also not useful. Instead, symptom pattern (episodic (viral) and multiple trigger) should be used to decide on treatment. Reduced lung function at birth is associated with a number of maternal factors, including smoking (both by direct and epigenetic mechanisms), atopic status, and pregnancy complications; these children tend to have transient wheeze. Children whose symptoms persist into mid-childhood are born with normal lung function, but have evidence of airflow obstruction at 4-6 years of age. Early atopic sensitization is important in this group. Treatment of pre-school wheeze should be based on relief of present symptoms; there is no known therapy which prevents progression from episodic to multiple trigger symptoms and asthma. Episodic (viral) wheeze is a neutrophilic disease and should be treated with intermittent therapy. Options include inhaled anticholinergics or short-acting β-2 agonists, oral leukotriene receptor antagonists and short-course, high-dose inhaled corticosteroids. Prophylactic inhaled corticosteroids are not useful. Neither prophylactic nor inhaled corticosteroids are effective in preventing progression from an episodic viral to a multiple-trigger pattern. Multipletrigger wheeze may merit a three-step trial (trial period, stop if apparent response, restart only if symptoms return) of prophylactic inhaled corticosteroids or leukotriene receptor antagonists. Recent data have shown that prednisolone should not be a routine treatment for acute exacerbations of episodic (viral) wheeze, but should only be used for really severe excacerbations, defined as being more severe than a routine admission and likely needing high dependency care. This is especially true in the setting of multiple trigger wheeze. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Acta Medica Lithuanica de Gruyter

The problem of preschool wheeze: new developments, new questions

Bush, Andrew
Acta Medica Lithuanica , Volume 17 – Jun 29, 2010
Download PDF
11 pages

Loading next page...
 
/lp/de-gruyter/the-problem-of-preschool-wheeze-new-developments-new-questions-Thw8QtpvGR
Publisher
de Gruyter
Copyright
Copyright © 2010 by the
ISSN
1392-0138
eISSN
2029-4174
DOI
10.2478/v10140-010-0006-8
Publisher site
See Article on Publisher Site

Abstract

The problem of preschool wheeze: new developments, new questions Preschool wheeze is a common and often difficult to treat symptom. It may rarely be the first presentation of a severe underlying condition. Preschool wheeze is clearly a syndrome, not a single entity, and thus ripe for phenotyping. A number of approaches to phenotyping have been adopted. Epidemiology, based on the temporal patterns of symptoms, has taught us a lot about the medium and long-term implications of early life events, but is not useful for treatment planning. Atopic status is also not useful. Instead, symptom pattern (episodic (viral) and multiple trigger) should be used to decide on treatment. Reduced lung function at birth is associated with a number of maternal factors, including smoking (both by direct and epigenetic mechanisms), atopic status, and pregnancy complications; these children tend to have transient wheeze. Children whose symptoms persist into mid-childhood are born with normal lung function, but have evidence of airflow obstruction at 4-6 years of age. Early atopic sensitization is important in this group. Treatment of pre-school wheeze should be based on relief of present symptoms; there is no known therapy which prevents progression from episodic to multiple trigger symptoms and asthma. Episodic (viral) wheeze is a neutrophilic disease and should be treated with intermittent therapy. Options include inhaled anticholinergics or short-acting β-2 agonists, oral leukotriene receptor antagonists and short-course, high-dose inhaled corticosteroids. Prophylactic inhaled corticosteroids are not useful. Neither prophylactic nor inhaled corticosteroids are effective in preventing progression from an episodic viral to a multiple-trigger pattern. Multipletrigger wheeze may merit a three-step trial (trial period, stop if apparent response, restart only if symptoms return) of prophylactic inhaled corticosteroids or leukotriene receptor antagonists. Recent data have shown that prednisolone should not be a routine treatment for acute exacerbations of episodic (viral) wheeze, but should only be used for really severe excacerbations, defined as being more severe than a routine admission and likely needing high dependency care. This is especially true in the setting of multiple trigger wheeze.

Journal

Acta Medica Lithuanica – de Gruyter

Published: Jun 29, 2010

References

  • What do parents of wheezy children understand by wheeze
    R. Cane
  • Wheeze detection: recordings vs. assessment of physician and parent
    M. Levy
  • Parents' interpretations of children's respiratory symptoms on video
    R. Cane
  • A video questionnaire identifies upper airway abnormalities in preschool children with reported wheeze
    S. Saglani
  • Problematic, severe asthma in children: a new concept, and how to manage it
    A. Bush
  • Viral upper respiratory tract infection and otitis media complication in young children
    T. Chonmaitree
  • The effect of hydrotherapy on the incidence of common cold episodes in children: a randomised clinical trial
    C. Grüber
  • Influence of attendance at day care on the common cold from birth through 13 years of age
    T. Ball
  • Misconceptions about colds and predictors of health service utilization
    G. Lee
  • Asthma and wheezing in the first years of life
    F. Martinez
  • Diminished lung function as a predisposing factor for wheezing respiratory illness in infants
    F. Martinez
  • NAC Manchester Asthma and Allergy Study Group. Wheeze phenotypes and lung function in preschool children
    L. Lowe
  • The relationship between infant airway function, childhood airway responsiveness, and asthma
    S. Turner
  • Associations of wheezing phenotypes in the first 6 years of life with atopy, lung function and airway responsiveness in mid-childhood
    J. Henderson
  • Distinguishing phenotypes of childhood wheeze and cough using latent class analysis
    B. Spycher